DR. HUI J. CHEN, M.D.
Radiology at Pasteur Dr, Palo Alto, CA
License number
California A98117
Category
Radiology
Type
Diagnostic Radiology
Address
Address
300 Pasteur Dr, Palo Alto, CA 94305
Phone
(650) 723-4000
Professional information
Methods And Compositions For Inhibiting Cell Proliferative Disorders
US Patent:
6596878, Jul 22, 2003
Filed:
Sep 18, 2001
Appl. No.:
09/953933
Inventors:
Hui Chen - Palo Alto CA
Aviv Gazit - Jerusalem, IL
Alexander Levitzki - Jerusalem, IL
Klaus Peter Hirth - San Francisco CA
Elaina Mann - Alameda CA
Laura K. Shawver - San Francisco CA
Jianming Tsai - San Francisco CA
Peng Cho Tang - Moraga CA
Aviv Gazit - Jerusalem, IL
Alexander Levitzki - Jerusalem, IL
Klaus Peter Hirth - San Francisco CA
Elaina Mann - Alameda CA
Laura K. Shawver - San Francisco CA
Jianming Tsai - San Francisco CA
Peng Cho Tang - Moraga CA
Assignee:
Yissum Research Development Company of the Hebrew University - Jerusalem
Sugen, Inc. - South San Francisco CA
Sugen, Inc. - South San Francisco CA
International Classification:
C07D23138
US Classification:
5483717, 558402, 558404
Abstract:
The present invention concerns compounds and their use to inhibit the activity of a receptor tyrosine kinase. The invention is preferably used to treat cell proliferative disorders such as cancers characterized by over-activity or inappropriate activity HER2 or EGFR.
Methods And Compositions For Inhibiting Cell Proliferative Disorders
US Patent:
5773476, Jun 30, 1998
Filed:
Jun 7, 1995
Appl. No.:
8/486775
Inventors:
Hui Chen - Palo Alto CA
Aviv Gazit - Jerusalem, IL
Alexander Levitzki - Jerusalem, IL
Klaus Peter Hirth - San Francisco CA
Elaina Mann - Alameda CA
Laura K. Shawver - San Francisco CA
Jianming Tsai - San Francisco CA
Peng Cho Tang - Moraga CA
Aviv Gazit - Jerusalem, IL
Alexander Levitzki - Jerusalem, IL
Klaus Peter Hirth - San Francisco CA
Elaina Mann - Alameda CA
Laura K. Shawver - San Francisco CA
Jianming Tsai - San Francisco CA
Peng Cho Tang - Moraga CA
Assignee:
Sugen, Inc. - Redwood City
Yissum Research and Development Company of the Hebrew University of
Jerusalem - Jerusalem
Yissum Research and Development Company of the Hebrew University of
Jerusalem - Jerusalem
International Classification:
A01N 3718
US Classification:
514620
Abstract:
The present invention concerns compounds and their use to inhibit the activity of a receptor tyrosine kinase. The invention is preferably used to treat cell proliferative disorders such as cancers charcterized by over-activity or inappropriate activity HER2 or EGFR.
Method And Compositions For Inhibiting Cell Proliferative Disorders
US Patent:
7217737, May 15, 2007
Filed:
Jun 25, 2003
Appl. No.:
10/602617
Inventors:
Hui Chen - Palo Alto CA, US
Aviv Gazit - Jerusalem, IL
Alexander Levitzki - Jerusalem, IL
Klaus Peter Hirth - San Francisco CA, US
Elaina Mann - Oakland CA, US
Peng Cho Tang - Moraga CA, US
Laura K. Shawver - San Francisco CA, US
Jianming Tsai - San Francisco CA, US
Aviv Gazit - Jerusalem, IL
Alexander Levitzki - Jerusalem, IL
Klaus Peter Hirth - San Francisco CA, US
Elaina Mann - Oakland CA, US
Peng Cho Tang - Moraga CA, US
Laura K. Shawver - San Francisco CA, US
Jianming Tsai - San Francisco CA, US
Assignee:
Yissum Research and Development Company of the Hebrew University of Jerusalem - Jerusalem
Sugen, Inc. - South San Francisco CA
Sugen, Inc. - South San Francisco CA
International Classification:
A61K 31/275
US Classification:
514523
Abstract:
The present invention concerns compounds and their use to inhibit the activity of a receptor tyrosine kinase. The invention is preferably used to treat cell proliferative disorders such as cancers characterized by over-activity or inappropriate activity HER2 or EGFR.
Methods And Compositions For Inhibiting Cell Proliferative Disorders
US Patent:
5789427, Aug 4, 1998
Filed:
Mar 7, 1995
Appl. No.:
8/399967
Inventors:
Hui Chen - Palo Alto CA
Aviv Gazit - Jerusalem, IL
Klaus Peter Hirth - San Francisco CA
Elaina Mann - Alameda CA
Laura K. Shawver - San Francisco CA
Jianming Tsai - San Francisco CA
Peng Cho Tang - Moraga CA
Aviv Gazit - Jerusalem, IL
Klaus Peter Hirth - San Francisco CA
Elaina Mann - Alameda CA
Laura K. Shawver - San Francisco CA
Jianming Tsai - San Francisco CA
Peng Cho Tang - Moraga CA
Assignee:
Sugen, Inc. - Redwood City CA
Yissum Research & Development Company of the Hebrew University of
Jerusalem - Jerusalem
Yissum Research & Development Company of the Hebrew University of
Jerusalem - Jerusalem
International Classification:
A01N 4340, C07D21172
US Classification:
514352
Abstract:
The present invention concerns compounds and their use to inhibit the activity of a receptor tyrosine kinase. The invention is preferably used to treat cell proliferative disorders such as cancers characterized by over-activity or inappropriate activity HER2 or EGFR.